{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:49:44Z","timestamp":1784958584344,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-1074\\u201322-62198"],"award-info":[{"award-number":["APQ-1074\\u201322-62198"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Fundacao de Amparo a Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-0855\\u201319"],"award-info":[{"award-number":["APQ-0855\\u201319"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305133\/2021\\u20137"],"award-info":[{"award-number":["305133\/2021\\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clinbiochem.2024.110765","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T22:23:34Z","timestamp":1713651814000},"page":"110765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A validated method for simultaneous quantification of four antiretrovirals in dried blood spot and plasma using LC-MS\/MS: Application to efavirenz therapeutic drug monitoring in pregnant patients"],"prefix":"10.1016","volume":"127-128","author":[{"given":"Maira","family":"Ludna Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurylanne","family":"Mikaelle Brand\u00e3o Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Wellithom Viturino da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi","family":"Pereira Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whocely","family":"Victor de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Cl\u00e1udio Arraes de Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"C\u00e9sar Galindo Bedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Bastos Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110765_b0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2125.2008.03220.x","article-title":"Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women","volume":"66","author":"Roustit","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejogrb.2020.11.034","article-title":"HIV in pregnancy \u2013 an update","volume":"256","author":"Chilaka","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0015","unstructured":"World Health Organization, Estimated number of pregnant women living with HIV. who received antiretrovirals for preventing mother-to-child transmission. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/estimated-number-of-pregnant-women-living-with-hiv-needing-antiretrovirals-for-preventing-mother-to-child-transmission, 2022 (accessed 27th November 2023)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0020","unstructured":"United Nations International Children's Emergency Fund, Elimination of mother-to-child transmission. https:\/\/data.unicef.org\/topic\/hivaids\/emtct\/, 2023 (accessed 27th November 2023)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200443150-00002","article-title":"Pharmacokinetics of antiretrovirals in pregnant women","volume":"43","author":"Mirochnick","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0030","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0035","unstructured":"Minist\u00e9rio da Sa\u00fade, Brazil, Protocolo cl\u00ednico e diretrizes terap\u00eauticas para preven\u00e7\u00e3o da transmiss\u00e3o vertical de HIV, s\u00edfilis e hepatites virais. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/protocolo_clinico_hiv_sifilis_hepatites.pdf, 2022 (accessed 27th November 2023)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FTD.0b013e318261c372","article-title":"Therapeutic drug monitoring in pregnancy","volume":"34","author":"Matsui","year":"2012","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/621780","article-title":"Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy","volume":"2009","author":"Weinberg","year":"2009","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00007691-200306000-00018","article-title":"Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care","volume":"25","author":"Maat","year":"2003","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0055","first-page":"288","article-title":"Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process","volume":"27","author":"Zakaria","year":"2016","journal-title":"EJIFCC."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40572-020-00289-y","article-title":"Little to give, much to gain\u2014what can you do with a dried blood spot?","volume":"7","author":"McClendon-Weary","year":"2020","journal-title":"Curr Envir Health Rpt."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0065","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.clinbiochem.2016.05.004","article-title":"Dried blood spots analysis with mass spectrometry: potentials and pitfalls in therapeutic drug monitoring","volume":"49","author":"Antunes","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot\u2013based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jms.3952","article-title":"Automated high throughput analysis of antiretroviral drugs in dried blood spots","volume":"52","author":"Duthaler","year":"2017","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0080","unstructured":"Food and Drug Administration, Bioanalytical method validation - guidance for industry. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf, 2018 (accessed 25 December 2021)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0085","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria, RDC n\u00b0 27 de 17 de maio de 2012. https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/anvisa\/2012\/rdc0027_17_05_2012.html, 2012 (accessed 25 December 2021)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0090","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0095","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/AOG.0b013e3181c2bde8","article-title":"Pregnancy and laboratory studies: a reference table for clinicians","volume":"114","author":"Abbassi-Ghanavati","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0100","series-title":"Hematological normal ranges in pregnancy","author":"Morton","year":"2021"},{"key":"10.1016\/j.clinbiochem.2024.110765_b0105","doi-asserted-by":"crossref","DOI":"10.4155\/bio.14.298","article-title":"What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?","volume":"7","author":"Koster","year":"2015","journal-title":"Bioanal."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0110","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I","volume":"21","author":"Passing","year":"1983","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry","volume":"21","author":"Jung","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0125","first-page":"371","volume":"23","author":"Ramakrishna","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based on effectiveness of protein removal and ionization effect in liquid chromatography - tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jac\/dks011","article-title":"Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz","volume":"67","author":"Kromdijk","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jac\/dkr498","article-title":"Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects","volume":"67","author":"Cattaneo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0145","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00003088-200544100-00003","article-title":"Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir","volume":"44","author":"Tiec","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0150","unstructured":"European Medicines Agency, Assessment report: Ritonavir Mylan. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/ritonavir-mylan-epar-public-assessment-report_en.pdf, 2017 (accessed 12 February 2022)."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002030-200101050-00011","article-title":"Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients","volume":"15","author":"Marzolini","year":"2001","journal-title":"AIDS."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0160","doi-asserted-by":"crossref","DOI":"10.4155\/bio.11.72","article-title":"Clinical evaluation of the determination of plasma concentrations of darunavir, etravirine, raltegravir and ritonavir in dried blood spot samples","volume":"3","author":"Ter Heine","year":"2011","journal-title":"Bioanal."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2008.04.003","article-title":"Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography\u2013triple quadrupole mass spectrometry","volume":"867","author":"Ter Heine","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0170","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/jac\/dky254","article-title":"Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions","volume":"73","author":"Duthaler","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/FTD.0b013e318156e73a","article-title":"Effect of anticoagulants on plasma nevirapine and efavirenz concentrations","volume":"29","author":"Kumar","year":"2007","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0180","doi-asserted-by":"crossref","DOI":"10.4155\/bio.14.151","article-title":"Current strategies for coping with the hematocrit problem in dried blood spot analysis","volume":"6","author":"De Kesel","year":"2014","journal-title":"Bioanal."},{"key":"10.1016\/j.clinbiochem.2024.110765_b0185","first-page":"e00845","article-title":"Dried blood spot technique-based liquid chromatography-tandem mass spectrometry method as a simple alternative for benznidazole pharmacokinetic assessment","volume":"62","author":"Bedor","year":"2018","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:11:15Z","timestamp":1762114275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"alternative-id":["S0009912024000596"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110765","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated method for simultaneous quantification of four antiretrovirals in dried blood spot and plasma using LC-MS\/MS: Application to efavirenz therapeutic drug monitoring in pregnant patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110765"}}